UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms and Total Bilirubin Levels in an Ethnically Diverse Cohort of Women
Authors:
- Andrew L. HongAHAndrew L. Hong
- Dezheng HuoDHDezheng Huo
- Hee-Jin KimHKHee-Jin Kim
- Qun NiuQNQun Niu
- Donna L. FackenthalDFDonna L. Fackenthal
- Shelly A. CummingsSCShelly A. Cummings
- Esther M. JohnEJEsther M. John
- Dee W. WestDWDee W. West
- Alice S. WhittemoreAWAlice S. Whittemore
- Soma DasSDSoma Das
- Olufunmilayo I. OlopadeOOOlufunmilayo I. Olopade
- 1 August 2007
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 35 (8) , 1254-1261
Abstract
The objective of this study was to investigate variations in UGT1A1 polymorphisms and haplotypes among African-American and Caucasian women and to assess whether variants other than UGT1A1*28 are associated with total serum bilirubin levels. The (TA)n repeats and 14 single nucleotide polymorphisms (SNPs) in the UGT1A1 gene were genotyped in 335 African Americans and 181 Caucasians. Total serum bilirubin levels were available in a subset of 125 women. Allele frequencies of all SNPs and (TA)n repeats were significantly different between African Americans and Caucasians. In Caucasians, three common haplotypes accounted for 71.8% of chromosomes, whereas five common haplotypes accounted for only 46.6% of chromosomes in African Americans. Mean total serum bilirubin levels were significantly lower (p = 0.005) in African Americans (0.36 mg/dl) than in Caucasians (0.44 mg/dl). The (TA)n repeats explained a significant amount of variation in total bilirubin levels (R2 = 0.27, p < 0.0001), whereas other SNPs were less correlative. Thus, significant variations in UGT1A1 haplotype structure exist between African Americans and Caucasians in this relatively large cohort of women. The correlation of UGT1A1 with total bilirubin levels was mainly due to (TA)n repeats in Caucasians but a clear correlation was not observed in African Americans because of the high diversity of haplotypes and the small sample size. These data have implications for the design of epidemiologic studies of cancer susceptibility and pharmacogenetic studies for adverse drug reactions in populations of African ancestry.Keywords
This publication has 37 references indexed in Scilit:
- Association Between the UGT1A1*28 Allele, Bilirubin Levels, and Coronary Heart Disease in the Framingham Heart StudyCirculation, 2006
- Comparative genomics analysis of human sequence variation in the UGT1A gene clusterThe Pharmacogenomics Journal, 2005
- The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b ]pyridine in vivoCarcinogenesis, 2005
- RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICANDrug Metabolism and Disposition, 2005
- Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjectsHepatology Research, 2004
- Serum bilirubin levels in the U.S. population: Gender effect and inverse correlation with colorectal cancerHepatology, 2004
- The International HapMap ProjectNature, 2003
- A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype DataThe American Journal of Human Genetics, 2003
- UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicityThe Pharmacogenomics Journal, 2002
- Bilirubin UDP-glucuronosyltransferase1A1 gene polymorphisms: Susceptibility to oxidative damage and cancer?Molecular Carcinogenesis, 2000